Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: Suppl. 5

Hypertension in the elderly

Yaşlılarda hipertansiyon

Pages
29–31
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Goal blood pressure recommendation for most hypertensive elderly is to attain a systolic pressure below 140 mmHg

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertension (HT) is a common problem in elderly persons (age >65 years), reaching a prevalence as high as 60 to 80%.
📊
Key Findings & Data:Randomized trials have provided clear evidence of benefit from treating HT in elderly patients, including those over the age of 80 years.
💡
Conclusion & Impact:Goal blood pressure recommendation for most hypertensive elderly is to attain a systolic pressure below 140 mmHg
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hypertension (HT) is a common problem in elderly persons (age >65 years), reaching a prevalence as high as 60 to 80%. Isolated systolic HT mostly occurs in older patients. Treatment of HT in all patients, independent of age, consists of lifestyle modifications and antihypertensive therapy. Randomized trials have provided clear evidence of benefit from treating HT in elderly patients, including those over the age of 80 years. Drug therapy should be started in elderly hypertensive patients if lifestyle changes are insufficient and in the absence of a hypertensive emergency or urgency, blood pressure reduction should always be gradual. A long-acting dihydropyridine or a thiazide diuretic is generally preferred because of increased blood pressure-lowering efficacy in this population. Goal blood pressure recommendation for most hypertensive elderly is to attain a systolic pressure below 140 mmHg

Özet

Yaşlılarda (>65 yaş) hipertansiyon (HT) %60-80 oranında görülebilen yaygın bir problemdir. Yaşlılarda izole sistolik HT daha sık görülür. Tüm HT hastalarında yaş önemli olmaksızın, tedavi, yaşam tarzı değişikliklerini ve antihipertansif ilaç tedavisini kapsar. Randomize çalışmalarda yaşlı (>65 yaş) ve çok yaşlı (>80 yaş) hastalarda antihipertansif tedavinin yararı gösterilmiştir. Eğer yaşam tarzı değişiklikleri ile yeterli kan basıncı düşüşü sağlanamıyorsa ilaç tedavisi başlanmalıdır. Acil bir durum yoksa yaşlılarda kan basıncı kademeli bir şekilde düşürülmelidir. Uzun etkili kalsiyum kanal blokerleri ve tiazid diüretiklerinin yaşlılarda kan basıncı düşürücü etkileri daha belirgindir. Çoğu yaşlı hipertansif hastada sistolik kan basıncının 140 mmHg altında olması hedeflenir.

🔖

Cite This Article

ÇAKAN, F. Ö. (2022). Hypertension in the elderly. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: Suppl. 5, 29–31. https://ajindex.com/articles/632243

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Forceon Clinical Expert Consensus Documents. Circulation 2011;123:2434–506
  2. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Doesthe relation of blood pressure to coronary heart disease risk change with aging?The Framingham Heart Study. Circulation 2001;103:1245–9
  3. Izzo JL Jr, Levy D, Black HR. Clinical Advisory Statement. Importance ofsystolic blood pressure in older Americans. Hypertension 2000;35:1021–4
  4. Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–74
  5. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, etal. Hemodynamic patterns of age-related changes in blood pressure. The FraminghamHeart Study. Circulation 1997;96:308–15
  6. Messerli FH, Sundgaard-Riise K, Ventura HO, Dunn FG, Glade LB, Frohlich ED. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983;2:983–6
  7. Safar ME, Cloarec-Blanchard L, London GM. Arterial alterations in hypertension with a disproportionate increase in systolic over diastolic blood pressure. JHypertens Suppl 1996;14:S103–9
  8. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989;13:392–400
  9. Safar ME. Hemodynamic changes in elderly hypertensive patients. Am JHypertens 1993;6:20S–23S
  10. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20
  11. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865–72
  12. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Syst